Paris, France

Laurent Pradier

This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Pradier. Retrieved from https://idiyas.com/inventor/laurent-pradier-rp3sm190

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Pradier

Introduction

Laurent Pradier is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. His innovative work has garnered attention and respect within the scientific community.

Latest Patents

Laurent Pradier holds a patent for "Neutralizing Anti-Amyloid Beta Antibodies for the Treatment of Alzheimer's Disease." This patent represents a crucial step in developing therapies aimed at combating the effects of Alzheimer's, a condition that affects millions worldwide. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Pradier is affiliated with The Brigham and Women's Hospital, Inc., where he collaborates with other researchers to explore new treatment options for neurodegenerative diseases. His work is characterized by a dedication to improving patient outcomes through innovative research.

Collaborations

Throughout his career, Laurent has worked alongside esteemed colleagues such as Ming Jin and David Reczek. These collaborations have enriched his research and contributed to the development of groundbreaking therapies.

Conclusion

Laurent Pradier's contributions to the field of Alzheimer's research highlight the importance of innovation in medicine. His patent and collaborative efforts reflect a commitment to improving the lives of those affected by this challenging disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…